Compare GXO & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GXO | MMED |
|---|---|---|
| Founded | 2021 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.5B |
| IPO Year | 2021 | 2025 |
| Metric | GXO | MMED |
|---|---|---|
| Price | $48.73 | $18.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 17 |
| Target Price | ★ $68.47 | $25.19 |
| AVG Volume (30 Days) | 992.4K | ★ 13.7M |
| Earning Date | 11-03-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $13,178,000,000.00 | $3,102,000,000.00 |
| Revenue This Year | $5.81 | $10.83 |
| Revenue Next Year | $4.86 | $8.37 |
| P/E Ratio | $194.08 | ★ N/A |
| Revenue Growth | 12.55 | ★ 14.25 |
| 52 Week Low | $43.61 | $10.65 |
| 52 Week High | $66.85 | $24.43 |
| Indicator | GXO | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 43.54 |
| Support Level | $48.11 | $16.55 |
| Resistance Level | $51.73 | $20.88 |
| Average True Range (ATR) | 1.19 | 0.94 |
| MACD | 0.34 | -0.08 |
| Stochastic Oscillator | 83.07 | 46.97 |
GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.